Nodal Marginal Zone Lymphoma

18 clinical trials · Condition

Record	Firm	Date
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. (NCT04223765)	UNC Lineberger Comprehensive Cancer Center	2020-11-12
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas (NCT03697512)	International Extranodal Lymphoma Study Group (IELSG)	2019-09-27
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715)	Mayo Clinic	2016-01-19
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection (NCT02109224)	National Cancer Institute (NCI)	2014-09-01
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma (NCT01567709)	National Cancer Institute (NCI)	2012-04-16
Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma (NCT01701232)	Biocad	2011-09-01
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors (NCT01326702)	National Cancer Institute (NCI)	2011-07-01
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers (NCT01254578)	National Cancer Institute (NCI)	2010-11-24
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery (NCT00608361)	National Cancer Institute (NCI)	2008-10-01
Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma (NCT00711828)	Mayo Clinic	2008-08-01
Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma (NCT00253630)	National Cancer Institute (NCI)	2005-09-01
Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma (NCT00438880)	Mayo Clinic	2004-10-01
Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma (NCT00082888)	National Cancer Institute (NCI)	2004-03-24
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms (NCT00082784)	National Cancer Institute (NCI)	2004-03-01

Track Nodal Marginal Zone Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.